Yahoo Finance via Directus cache · updated daily · 2026-07-13
| CVE ID | Severity | Patch | EPSS | Date |
|---|---|---|---|---|
| CVE-2025-4397 | 6.8 MEDIUM | PATCH UNDER REVIEW | 0.01% | 2026-05-07 |
| CVE-2025-4386 PoC | 6.8 MEDIUM | PATCH UNDER REVIEW | 0.03% | 2026-05-07 |
| CVE-2025-12997 PoC | 2.2 LOW | PATCH UNDER REVIEW | 0.03% | 2025-12-04 |
| CVE-2025-12996 | 4.1 MEDIUM | PATCH UNDER REVIEW | 0.01% | 2025-12-04 |
| CVE-2025-12995 PoC | 8.1 HIGH | PATCH UNDER REVIEW | 0.09% | 2025-12-04 |
| CVE-2025-12994 PoC | 5.3 MEDIUM | PATCH UNDER REVIEW | 0.04% | 2025-12-04 |
| CVE-2025-4395 | 6.8 MEDIUM | PATCH UNDER REVIEW | 0.15% | 2025-07-24 |
| CVE-2025-4394 | 6.8 MEDIUM | PATCH UNDER REVIEW | 0.08% | 2025-07-24 |
| CVE-2025-4393 PoC | 6.5 MEDIUM | PATCH UNDER REVIEW | 0.11% | 2025-07-24 |
| CVE-2023-31222 | 9.8 CRITICAL | PATCH UNDER REVIEW | 28.29% | 2023-06-29 |
| CVE-2020-25183 | 8.0 HIGH | PATCH UNDER REVIEW | 0.79% | 2020-12-14 |
| CVE-2020-25187 PoC | 8.8 HIGH | PATCH UNDER REVIEW | 3.77% | 2020-12-14 |
| CVE-2020-27252 | 8.8 HIGH | PATCH UNDER REVIEW | 3.68% | 2020-12-14 |
| CVE-2019-13539 | 7.0 HIGH | PATCH UNDER REVIEW | 0.27% | 2019-11-08 |
| CVE-2019-10964 | 7.1 HIGH | PATCH UNDER REVIEW | 1.23% | 2019-06-28 |
| CVE-2019-6538 | 9.3 CRITICAL | PATCH UNDER REVIEW | 0.90% | 2019-03-25 |
| CVE-2018-10596 PoC | 7.1 HIGH | PATCH UNDER REVIEW | 1.32% | 2018-07-02 |
Medtronic is a global medical technology company that develops and manufactures medical devices, including pacemakers, insulin pumps, and neurostimulators. Their products increasingly rely on embedded software and wireless connectivity, making them a significant focus for cybersecurity in healthcare due to potential patient safety risks from vulnerabilities.
Based on 2 critical CVEs, 0 CISA KEV, 0% unpatched. Model: GDPR Art.83 · not legal advice.